These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27832278)

  • 1. IL-17A Promotes RANTES Expression, But Not IL-16, in Orbital Fibroblasts Via CD40-CD40L Combination in Thyroid-Associated Ophthalmopathy.
    Fang S; Huang Y; Zhong S; Zhang Y; Liu X; Wang Y; Gu P; Zhou H; Fan X
    Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6123-6133. PubMed ID: 27832278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-κB.
    Gillespie EF; Raychaudhuri N; Papageorgiou KI; Atkins SJ; Lu Y; Charara LK; Mester T; Smith TJ; Douglas RS
    Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7746-53. PubMed ID: 23092922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-17A Exacerbates Fibrosis by Promoting the Proinflammatory and Profibrotic Function of Orbital Fibroblasts in TAO.
    Fang S; Huang Y; Wang S; Zhang Y; Luo X; Liu L; Zhong S; Liu X; Li D; Liang R; Miranda P; Gu P; Zhou H; Fan X; Li B
    J Clin Endocrinol Metab; 2016 Aug; 101(8):2955-65. PubMed ID: 27224264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1.
    Hwang CJ; Afifiyan N; Sand D; Naik V; Said J; Pollock SJ; Chen B; Phipps RP; Goldberg RA; Smith TJ; Douglas RS
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2262-8. PubMed ID: 19117935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated IL-38 inhibits IL-23R expression and IL-17A production in thyroid-associated ophthalmopathy.
    Pan Y; Wang M; Chen X; Chen Y; Ai S; Wang M; Su W; Liang D
    Int Immunopharmacol; 2021 Feb; 91():107300. PubMed ID: 33383445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights Into Local Orbital Immunity: Evidence for the Involvement of the Th17 Cell Pathway in Thyroid-Associated Ophthalmopathy.
    Fang S; Huang Y; Wang N; Zhang S; Zhong S; Li Y; Sun J; Liu X; Wang Y; Gu P; Li B; Zhou H; Fan X
    J Clin Endocrinol Metab; 2019 May; 104(5):1697-1711. PubMed ID: 30517642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid induces COX-2 expression via CD44 in orbital fibroblasts from patients with thyroid-associated ophthalmopathy.
    Lim HS; Back KO; Kim HJ; Choi YH; Park YM; Kook KH
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7441-50. PubMed ID: 25342622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA aptamers with specific binding affinity to CD40 (CD40Apt) represents a promising antagonist of the CD40-CD40L signaling for thyroid-associated ophthalmopathy (TAO) treatment in mouse.
    Chen Y; Tang R; Xiong W; Zhang F; Wang N; Xie B; Cao J; Chen Z; Ma C
    J Transl Med; 2023 Jun; 21(1):396. PubMed ID: 37331977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octreotide inhibits secretion of IGF-1 from orbital fibroblasts in patients with thyroid-associated ophthalmopathy via inhibition of the NF-κB pathway.
    Kim SE; Kim J; Lee JY; Lee SB; Paik JS; Yang SW
    PLoS One; 2021; 16(4):e0249988. PubMed ID: 33886620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-L1 Inhibits T Cell-Induced Cytokines and Hyaluronan Expression
    Liu Z; Liu Y; Liu M; Gong Q; Shi A; Li X; Bai X; Guan X; Hao B; Liu F; Zhou X; Yuan H
    Front Immunol; 2022; 13():849480. PubMed ID: 35619700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40 ligand induces expression of vascular cell adhesion molecule 1 and E-selectin in orbital fibroblasts from patients with Graves' orbitopathy.
    Wang H; Zhu LS; Cheng JW; Cai JP; Li Y; Ma XY; Wei RL
    Graefes Arch Clin Exp Ophthalmol; 2015 Apr; 253(4):573-82. PubMed ID: 25576172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of intercellular adhesion molecule-1 induced by CD40-CD40L ligand signaling in orbital fibroblasts in patients with Graves' ophthalmopathy.
    Zhao LQ; Wei RL; Cheng JW; Cai JP; Li Y
    Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4652-60. PubMed ID: 20107176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palmitate induced secretion of IL-6 and MCP-1 in orbital fibroblasts derived from patients with thyroid-associated ophthalmopathy.
    Paik JS; Cho WK; Oh EH; Lee SB; Yang SW
    Mol Vis; 2012; 18():1467-77. PubMed ID: 22736938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locally produced insulin-like growth factor-1 by orbital fibroblasts as implicative pathogenic factor rather than systemically circulated IGF-1 for patients with thyroid-associated ophthalmopathy.
    Song D; Wang R; Zhong Y; Li W; Li H; Dong F
    Graefes Arch Clin Exp Ophthalmol; 2012 Mar; 250(3):433-40. PubMed ID: 22159761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Orbital Fibrosis and Adipogenesis by Pathogenic Th17 Cells in Graves Orbitopathy.
    Fang S; Huang Y; Zhong S; Li Y; Zhang Y; Li Y; Sun J; Liu X; Wang Y; Zhang S; Xu T; Sun X; Gu P; Li D; Zhou H; Li B; Fan X
    J Clin Endocrinol Metab; 2017 Nov; 102(11):4273-4283. PubMed ID: 28938397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pirfenidone attenuates IL-1β-induced COX-2 and PGE2 production in orbital fibroblasts through suppression of NF-κB activity.
    Choi YH; Back KO; Kim HJ; Lee SY; Kook KH
    Exp Eye Res; 2013 Aug; 113():1-8. PubMed ID: 23664858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotropin receptor and CD40 mediate interleukin-8 expression in fibrocytes: implications for thyroid-associated ophthalmopathy (an American Ophthalmological Society thesis).
    Douglas RS; Mester T; Ginter A; Kim DS
    Trans Am Ophthalmol Soc; 2014; 112():26-37. PubMed ID: 25411513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of human orbital fibroblasts cultivated from intraconal, nasal and central adipose tissues.
    Kim JA; Ahn D; Kim BY; Choi YJ; Shin HJ; Jang SY
    Br J Ophthalmol; 2021 Feb; 105(2):290-296. PubMed ID: 31488432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Potential Role of Osteopontin in the Pathogenesis of Graves' Ophthalmopathy.
    Lou H; Wu LQ; Wang H; Wei RL; Cheng JW
    Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):18. PubMed ID: 34546326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent expression of IL-1 receptor antagonists in CD34⁺ fibrocytes and orbital fibroblasts in thyroid-associated ophthalmopathy: contribution of fibrocytes to orbital inflammation.
    Li B; Smith TJ
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2783-90. PubMed ID: 23633206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.